Education
About Us
Working with TipRanks
Follow Us
Biomx Inc. (PHGE)
:PHGE
Bx004
Cystic Fibrosis (Cf), Chronic Pseudomonas Aeruginosa Infection
Phase II
Recruiting
Study With Phage for CF Subjects With Pseudomonas Lung Infection
May 10, 2025
―
Bx005-A
Atopic Dermatitis
Phase I/II
Withdrawn
A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis
Jan 23, 2022
―
Bx004-A
Cystic Fibrosis, Chronic Pseudomonas Aeruginosa Infection
Phase I/II
Completed
Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection
Aug 11, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Biomx Inc. (PHGE) have in its pipeline
PHGE is currently developing the following drugs: Bx004, Bx005-A, Bx004-A. These drug candidates are in various stages of clinical development as the company works toward FDA approval.